1Hans L Rieder. Interventions for Tuberculosis Control and Elimination[M]. Paris: International Union Against Tuberculosis and Lung Disease, 2002 : 101 -- 103. 被引量：1
2Lotte A, Wasz-Hockert O, Poisson N, Dumitresca N, Verron M, Couvet E. BCG complications, Estimates of the risks among vaccinated subjects and statistical analysis, of their main characteristics [J]. Adv Tuberc Res, 1984,21 : 107-- 193. 被引量：1
1Millec FJW,Seel RME,Taylor MD.Tubereculosis in children[M].Cherchill Ltd London,1963:339. 被引量：1
2Starke JR.Tubereculosis in children.Semin Respir Crit Care Med[J],2004,(25):353-363. 被引量：1
3Buss J.Fujiwara P.Diagnosis standards and classification of tubereculosis in adults and children[J].Am J Respir Crit Care Med,2000,161:1376-1395. 被引量：1
4Chuura K,Chan ED.Tubereculosis in elderly[J].J Respir Dis,2006,27(7):301-315. 被引量：1
5Efferen LS.Tubereculosis in pregnaney[J].J Respir Dis,2006,27(8):338-347. 被引量：1
8Lugosi L. Theoretical and methodological aspects of BCG vaccine from the discovery of Calmette and Guerin to molecular biology: a review[J]. Tuber Lung Dis , 1992, 73 (3) : 252-261. 被引量：1
9WHO. A Discussion Document. Geneva: Department of Vaccines and Biotogicals[S]. 1999. 被引量：1
10Clemens JD, Chuong JJH, Feinstein AR. The BCG controversy: a methodological and statistical reappraisal[J]. JAMA, 1983, 249: 2362-2369. 被引量：1
